GlassScriptPhysician profile
Sneh Lavingia
NPI 1902168545
$3,566.09
in general payments reported to CMS, 2019-2025
15 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2021: $280 · 2022: $66.44 · 2023: $1,036 · 2024: $1,124 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,744.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,538.62 | 2023-2025 | Inspire |
| Medtronic, INC. | $728.52 | 2021-2025 | Endurant Iis, Sinuva, In.Pact Admiral |
| Bolton Medical INC | $330.55 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic Vascular, INC. | $253.76 | 2019 | |
| Aerin Medical INC. | $196.86 | 2024 | |
| Hologic Sales and Service, LLC | $136.06 | 2024 | Coolseal Generator |
| Tactile Systems Technology INC | $114.72 | 2021 | |
| Olympus America INC. | $67.61 | 2023 | |
| Intersect Ent, INC. | $39.34 | 2019 | |
| Medtronic USA, INC. | $39.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.31 | 2021-2022 | |
| Stryker Corporation | $28.61 | 2019 | |
| Optinose US, INC. | $23.24 | 2019 | |
| Innovation Technologies INC | $20.15 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sneh Lavingia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.